Michael J. Sernyak

2.7k total citations
58 papers, 1.9k citations indexed

About

Michael J. Sernyak is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Social Psychology. According to data from OpenAlex, Michael J. Sernyak has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 14 papers in Economics and Econometrics and 13 papers in Social Psychology. Recurrent topics in Michael J. Sernyak's work include Schizophrenia research and treatment (39 papers), Mental Health Treatment and Access (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Michael J. Sernyak is often cited by papers focused on Schizophrenia research and treatment (39 papers), Mental Health Treatment and Access (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Michael J. Sernyak collaborates with scholars based in United States, Netherlands and Australia. Michael J. Sernyak's co-authors include Robert A. Rosenheck, Douglas Leslie, Renato D. Alarcón, Miklos Losonczy, Tony Cohn, Robert Rosenheck, Scott W. Woods, John W. Newcomer, Bruce E. Wexler and Rani A. Desai and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

Michael J. Sernyak

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Sernyak United States 26 1.3k 357 305 229 219 58 1.9k
J. Peuskens Belgium 29 1.7k 1.3× 408 1.1× 662 2.2× 293 1.3× 219 1.0× 87 2.6k
Tim Lambert Australia 23 1.1k 0.8× 185 0.5× 513 1.7× 249 1.1× 146 0.7× 69 1.7k
Dov Aizenberg Israel 29 1.7k 1.3× 258 0.7× 721 2.4× 170 0.7× 357 1.6× 95 2.7k
William Montgomery United States 25 1.3k 1.0× 113 0.3× 469 1.5× 158 0.7× 331 1.5× 88 2.3k
W.W. Fleischhacker Austria 27 1.5k 1.2× 211 0.6× 387 1.3× 290 1.3× 409 1.9× 58 2.5k
Heike Hunger Germany 13 1.5k 1.1× 233 0.7× 282 0.9× 245 1.1× 273 1.2× 14 1.9k
John Lally United Kingdom 27 2.0k 1.5× 223 0.6× 607 2.0× 388 1.7× 232 1.1× 99 3.4k
Donna A. Wirshing United States 28 2.4k 1.8× 549 1.5× 653 2.1× 483 2.1× 379 1.7× 50 3.4k
Joan Mackell United States 23 1.7k 1.3× 189 0.5× 374 1.2× 95 0.4× 355 1.6× 54 2.4k
J. Peuskens Belgium 11 1.2k 0.9× 93 0.3× 436 1.4× 272 1.2× 274 1.3× 19 1.9k

Countries citing papers authored by Michael J. Sernyak

Since Specialization
Citations

This map shows the geographic impact of Michael J. Sernyak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Sernyak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Sernyak more than expected).

Fields of papers citing papers by Michael J. Sernyak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Sernyak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Sernyak. The network helps show where Michael J. Sernyak may publish in the future.

Co-authorship network of co-authors of Michael J. Sernyak

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Sernyak. A scholar is included among the top collaborators of Michael J. Sernyak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Sernyak. Michael J. Sernyak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Annamalai, Aniyizhai, Robert M. Rohrbaugh, & Michael J. Sernyak. (2015). General Medicine Training in Psychiatry Residency. Academic Psychiatry. 39(4). 437–441. 5 indexed citations
2.
Hermes, Eric D. A., Michael J. Sernyak, & Robert A. Rosenheck. (2013). Use of Second-Generation Antipsychotic Agents for Sleep and Sedation: A Provider Survey. SLEEP. 36(4). 597–600. 43 indexed citations
3.
Hermes, Eric D. A., Michael J. Sernyak, & Robert A. Rosenheck. (2013). The use of second generation antipsychotics for post-traumatic stress disorder in a US Veterans Health Administration Medical Center. Epidemiology and Psychiatric Sciences. 23(3). 281–288. 7 indexed citations
4.
Chwastiak, Lydia, et al.. (2012). Preventive Counseling for Chronic Disease: Missed Opportunities in a Community Mental Health Center. Psychosomatics. 54(4). 328–335. 29 indexed citations
5.
Hermes, Eric D. A., et al.. (2012). Impact of a program encouraging the use of generic antipsychotics.. PubMed. 18(8). e307–14. 5 indexed citations
6.
Aggarwal, Neil Krishan, Michael J. Sernyak, & Robert A. Rosenheck. (2012). Prevalence of Concomitant Oral Antipsychotic Drug Use Among Patients Treated With Long-Acting, Intramuscular, Antipsychotic Medications. Journal of Clinical Psychopharmacology. 32(3). 323–328. 33 indexed citations
7.
Mohamed, Somaia, Robert A. Rosenheck, Ilan Harpaz‐Rotem, Douglas Leslie, & Michael J. Sernyak. (2009). Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia. Psychiatric Quarterly. 80(4). 241–249. 16 indexed citations
8.
Sernyak, Michael J. & Robert A. Rosenheck. (2008). Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006. Psychiatric Services. 59(5). 567–569. 34 indexed citations
9.
Sernyak, Michael J. & Robert A. Rosenheck. (2007). Generic Fluoxetine and Choice of Antidepressant Medication. Psychiatric Services. 58(1). 128–130. 3 indexed citations
10.
Rosenheck, Robert A., Douglas Leslie, Susan H. Busch, Ethan S. Rofman, & Michael J. Sernyak. (2007). Rethinking Antipsychotic Formulary Policy. Schizophrenia Bulletin. 34(2). 375–380. 13 indexed citations
11.
Casey, Daniel E., Dan Haupt, John W. Newcomer, et al.. (2004). Schizophrenia, Metabolic Disorders, and Cardiovascular Disease. The Journal of Clinical Psychiatry. 65. 8–8. 2 indexed citations
12.
Sernyak, Michael J. & Robert Rosenheck. (2004). Economic Grand Rounds: Systemwide Costs Associated With Second-Generation Antipsychotics in the Treatment of Schizophrenia. Psychiatric Services. 55(12). 1361–1362.
13.
Sernyak, Michael J., David J. Dausey, Rani A. Desai, & Robert A. Rosenheck. (2003). Prescribers' Nonadherence to Treatment Guidelines for Schizophrenia When Prescribing Neuroleptics. Psychiatric Services. 54(2). 246–248. 32 indexed citations
14.
Sernyak, Michael J., Douglas Leslie, Renato D. Alarcón, Miklos Losonczy, & Robert A. Rosenheck. (2002). Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia. American Journal of Psychiatry. 159(4). 561–566. 470 indexed citations
15.
Woods, Scott W., et al.. (2001). Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients. Schizophrenia Research. 52(1-2). 21–27. 14 indexed citations
16.
Rosenheck, Robert, Douglas Leslie, & Michael J. Sernyak. (2001). From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs. Medical Care. 39(3). 302–308. 57 indexed citations
17.
Sernyak, Michael J., et al.. (1997). Chronic Neuroleptic Exposure in Bipolar Outpatients. The Journal of Clinical Psychiatry. 58(5). 193–195. 26 indexed citations
18.
Cappiello, Angela, Michael J. Sernyak, Robert T. Malison, et al.. (1997). Effects of Acute Tryptophan Depletion in Lithium-Remitted Manic Patients: A Pilot Study. Biological Psychiatry. 42(11). 1076–1078. 26 indexed citations
19.
Wexler, Bruce E., et al.. (1997). Normal neurocognitive performance after extended practice in patients with schizophrenia. Schizophrenia Research. 26(2-3). 173–180. 49 indexed citations
20.
Sernyak, Michael J., et al.. (1995). Schizophrenia and Strabismus. The Journal of Nervous and Mental Disease. 183(10). 662–662. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Peuskens Breakdown of academic impact, for papers by Tim Lambert Breakdown of academic impact, for papers by Dov Aizenberg Breakdown of academic impact, for papers by William Montgomery Breakdown of academic impact, for papers by W.W. Fleischhacker Breakdown of academic impact, for papers by Heike Hunger Breakdown of academic impact, for papers by John Lally Breakdown of academic impact, for papers by Donna A. Wirshing Breakdown of academic impact, for papers by Joan Mackell Breakdown of academic impact, for papers by J. Peuskens
Rankless by CCL
2026